West Pharmaceutical Services | WST - Gross Profit On Sales


West Pharmaceutical Services reported $296.4M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Align Technology USD 757.43M 20.84M Jun/2026
Baxter International USD 1.14B 251M Jun/2026
Becton, Dickinson and Co. USD 2.32B 161M Jun/2026
Cerus USD 33.33M 8.66M Dec/2024
Charles River Laboratories USD 348.78M 69.47M Jun/2026
Cooper Companies USD 735.4M 40.2M Mar/2026
Dentsply International USD 493M 66M Jun/2026
Haemonetics USD 202.8M 4.59M Jun/2026
ICU Medical USD 235.05M 28.83M Jun/2026
Insulet USD 562.6M 21.8M Jun/2026
Integra LifeSciences USD 215.97M 2.77M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
J&J USD 18.55B 1.31B Jun/2026
Medtronic USD 6.01B 595M Mar/2026
Merit Medical Systems USD 215.17M 30.37M Jun/2026
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Quidel USD 223.9M 315.7M Jun/2026
Repligen USD 110.04M 1.75M Jun/2026
Rockwell Medical USD 4.55M 1.49M Jun/2024
Solventum Corp USD 1.29B 189M Jun/2026
STAAR Surgical USD 43.74M 34.13M Dec/2025
Terumo JPY 178.54B 29.52B Jun/2026
Utah Medical Products USD 5.8M 450K Sep/2024
West Pharmaceutical Services USD 296.4M 7.5M Mar/2026